Versant Venture Management, LLC Top Holdings and 13F Report (2024) → Your $200 account credit is about to expire (From MarketBeat) (Ad) About Versant Venture Management, LLCInvestment ActivityVersant Venture Management, LLC has $103.14 million in total holdings as of March 31, 2024.Versant Venture Management, LLC owns shares of 7 different stocks, but just 4 companies or ETFs make up 80% of its holdings.Approximately 30.45% of the portfolio was purchased this quarter.About 373.47% of the portfolio was sold this quarter.This quarter, Versant Venture Management, LLC has purchased 7 new stocks and bought additional shares in 0 stocks.Versant Venture Management, LLC sold shares of 1 stock and completely divested from 1 stock this quarter.Largest Holdings CRISPR Therapeutics $33,981,713Skye Bioscience, Inc. $31,400,459Repare Therapeutics $12,465,754Gritstone bio $9,152,156Adverum Biotechnologies $7,166,463 Largest New Holdings this Quarter Skye Bioscience, Inc. $31,400,459 Holding Largest Purchases this Quarter Skye Bioscience, Inc. 2,007,702 shares (about $31.40M) Largest Sales this Quarter Adverum Biotechnologies 4,561,411 shares (about $64.50M) Sector Allocation Over TimeMap of 500 Largest Holdings ofVersant Venture Management, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorCRSPCRISPR Therapeutics$33,981,7130.0%498,55832.9%MedicalSkye Bioscience, Inc.$31,400,459$31,400,459 ▲New Holding2,007,70230.4%Common StockRPTXRepare Therapeutics$12,465,7540.0%2,646,65712.1%MedicalGRTSGritstone bio$9,152,1560.0%3,561,1508.9%MedicalADVMAdverum Biotechnologies$7,166,463$64,498,351 ▼-90.0%506,8226.9%MedicalPASGPassage Bio$6,695,6880.0%4,959,7696.5%MedicalALGSAligos Therapeutics$2,273,9730.0%2,320,3812.2%MedicalRayzeBio, Inc.$0$320,682,869 ▼-100.0%00.0%Common StockShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data: SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
